Investors in Sartorius were optimistic about the year 2024 on Tuesday. On the first trading day of the year, the shares of the laboratory equipment manufacturer led the DAX, which rose by 1.3 percent.
The US bank JPMorgan has given Sartorius shares Positive Catalyst Watch status and expects positive news on the occasion of the announcement of the fourth quarter figures on January 26. The rating was.
In his latest research note, analyst Richard Vosser confirms his negative recommendation. The broker JP Morgan is keeping its Sell rating. The target price is unchanged and still at CHF 230.